期刊文献+

痰湿型多囊卵巢综合征血清抗苗勒氏管激素水平的研究 被引量:4

Anti-MüLlerian Hormone Study of of Polycystic Ovary Syndrome with Phlegm-Dampness
下载PDF
导出
摘要 目的:探讨多囊卵巢综合征痰湿证临床及性激素、抗苗勒氏管激素(AMH)的特征性,从而为多囊卵巢综合征的中医规范化诊治提供依据。方法:以50例正常育龄妇女为对照组,150例PCOS患者分为两组:非痰湿组、痰湿组,其中非痰湿组99例,痰湿组51例,化学发光法测定血清性激素水平及AMH水平,同时比较3组初潮年龄、月经周期、BMI、腰围、SBP、DBP等临床指标的差异性。结果:①各组间临床特征比较:月经周期PCOS两组与对照组比较均有显著性差异(P<0.05);BMI、腰围PCOS痰湿组与对照组及非痰湿组比较均有显著性差异(P<0.05)。②各组间性激素及AMH的比较:LH、T、AMH值PCOS两组与对照组比较均有显著性差异(P<0.05);血清AMH值PCOS两组间比较也有显著性差异(P<0.05)。结论:多囊卵巢综合征痰湿证在BMI、腰围、AMH等水平具有特征性表达,提示痰湿证有胰岛素抵抗的倾向性。 Objective:To explore the characteristics of sex hormone and Anti -Miillerian hormone (AMH)in PCOS pa- tients with phlegm -dampness in order to give further basis on standardized diagnosis and teatment of PCOS. Methods :50 normal reproductive- aged women as controls, and 150 PCOS patients were divided into two groups: phlegm- dampness group and non phlegm- dampness group. Serum sex hormone, as well as AMH levels were measured by Chemilumines- cence. Indeics above and other parameters ( menstrual cycle, BMI, waist size, etc were compared among groups. Results : (1)clinical characteristics : menstrual cycle : PCOS groups 〉 control; BMI, waist size : phlegm - dampness PCOS group 〉 control, phlegm - dampness PCOS group 〉 non phlegm - dampness group (P 〈 0. 05 ). (2)sex hormone and AMH : LH, T, AMH levels: there were significant difference between PCOS groups and control, there were also significant difference of AMH between phlegm - dampness PCOS and non phlegm - dampness PCOS group ( P 〈 0. 05 ). Conclusions : There were characteristic expression on BMI, waist size, AMH in phlegm - dampness PCOS patients, they might have insulin resistance tendency.
作者 张宁
机构地区 山东中医药大学
出处 《中华中医药学刊》 CAS 2011年第9期1977-1979,共3页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81072758)
关键词 多囊卵巢综合征 痰湿 胰岛素抵抗 抗苗勒氏管激素 高雄激素血症 Polycystic ovary syndrome Phlegm - dampness Insulin resistance Anti - Miillerian hormone
  • 相关文献

参考文献8

  • 1Pigny P,Jonard S, Robert Y, et al. Serum anti -mullerian hormone as a surrogate for antral folliele count for definition of the polycystic ovary syndrome [J] .J Clin Endocrinol Metab,2005,91 (33) :941 -945.
  • 2The Rotterdam ESHRE/ASRM -Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long - term health risks related to polycystic ovary syndrome (PCOS) [ J ]. Human Reproduction,2004,19 ( 1 ) :41 - 47.
  • 3中华人民共和国卫生部.中药新药临床研究指导原则[s].北京:人民卫生出版社,1993.28~30.
  • 4李淑玲,常淑琴,王玖玲,李辉.多囊卵巢综合征中医证型与血清激素水平、胰岛素抵抗的相关性研究[J].上海中医药杂志,2007,41(7):51-52. 被引量:37
  • 5Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti - mullerian hormone in patients with polycystic ovary syndrome : relationship to the ovarian follicle excess and to the follicular arrest [ J]. J Clin Endocrinol Metab,2003,88 (12) :5957 - 5962.
  • 6Piltonen T, Morin - Papunen L, Koivunen R, et a. 1 Serum anti - m llerian hormone levels remain high until late reproductive' age and decrease during metformin therapy in women with polycystic ovary syndrome[J]. Hum Reprod, 2005, 20:1820 -1826.
  • 7Laven JS, MuldersAG, Visser JA, eta. 1 Anti - m llerian hormone serum concentrations in normoovulatory and anovulatorywomen of reproductive age [ J ]. JClin EndocrinolMetab, 2004, 89:318-323.
  • 8FlemingR, HarborueL, MacLaughlinDT, eta. l Metformin reduces serum mtillcrian - inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment [ J ]. FertilSteril,2005,83 : 130 - 136.

二级参考文献4

  • 1中华人民共和国卫生部.中药新药临床研究指导原则[s].北京:人民卫生出版社,1993.28~30.
  • 2The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromel (PCOS)[J].Human Reproduction,2004,19 (1):41-47.
  • 3Haffner SM,Miettinen H,Stern MP.The homeostasis model in the San Antonio Heart Study[J].Diabetes Care,1997,20 (7):1087-1093.
  • 4李诵弦,于传鑫.实用妇科内分泌学[M].上海:复旦大学出版社,2004:140.

共引文献557

同被引文献60

  • 1许青缓.淫羊藿对大鼠性腺功能的影响[J].中药药理与临床,1996,12(2):22-24. 被引量:36
  • 2宋知理.曹玲仙教授治疗多囊卵巢综合征经验撷要[J].江苏中医药,2006,27(12):12-13. 被引量:22
  • 3丰有吉.妇产科学[M].北京:人民卫生出版社,2000.347.
  • 4黄兆胜.中药学[M].北京:人民卫生出版社,2007:419-420
  • 5于传鑫,李诵铉.实用妇科内分泌学[M].2版.上海:复旦大学出版社,2006:442.
  • 6.中药新药临床研究指导原则(试行)[S].[S].国家药品监督管理局,2002..
  • 7缪希雍.神农本草经疏[M].北京:中国中医药出版社,1997:4.
  • 8程泾.实用中西医结合不孕不育诊疗学[M].北京:中国中医药出版社,2001:334.
  • 9Knoehenhauser ES, Key TJ, Kahsar-Milter M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States : a prospective study [ J ]. J Clin Endocrinol Metab, 1998,83 ( 9 ) : 3078 - 3082.
  • 10R. A. Lobo and E. Camina. The hnportance of Diagnosing the Polycyst Ovary Syndrome [ J ]. Ann Intern Med,2000.132 ( 12 ) :989 - 993.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部